Is ObsEva Restoring Lost Points of 2018?

From September 2018 to March 2020 ObsEva SA (NASDAQ: OBSV) had lost 15.5 points. April of 2020 became a turning point for OBSV to grow sharply until July 2020. Those times the stock could cost around $6 and biotech investors used to spot OBSV in case of any sharp movement.

A catastrophic fall in July to as low as $2.66 has pulled OBSV to trade above $3.00. Thanks to the clinical development program of Yselty which is dedicated to Uterine Fibroids. The testing stage is in phase 3 and has a long time to prep the therapeutic technology to treat the rare disease among women.

Due to the current media update, the stock could actually soar 19%. This could only be the beginning of the OBSV’s rise to recover to $18 value if the program is successful. During the trials, the stock will likely grow with weak volatility on millions of shares daily.